Clin2
NCT05503927Possibly a fitEnrolling by invitation

Study of Wegovy safety during pregnancy

PregnancyObesityOverweight

Part of Hormones & metabolism clinical trials.

This study looks at health outcomes for pregnant women and their babies after taking Wegovy or other weight-loss medicines. It may help understand if these medicines are safe during pregnancy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,701 people
Ages
15 years to 50 years
Study type
Observational

Who can take part

  • You were pregnant and had a pregnancy event like a live birth, stillbirth, or miscarriage between June 2021 and February 2034.
  • You were between 15 and 50 years old at the time you became pregnant.
  • You took Wegovy or another weight-loss medicine (like phentermine or orlistat) around the time you got pregnant or during pregnancy.
  • You had health insurance that covered medical and pharmacy benefits for at least 6 months before pregnancy and 42 days after the pregnancy ended.
  • You were not taking other similar diabetes or weight-loss medicines (like Ozempic) during the same time.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05872022Enrolling by invitation
Safety study of Wegovy exposure during pregnancy

This study tracks the safety of taking Wegovy during pregnancy. Researchers want to understand potential risks and outcomes when people are exposed to Wegovy in early or any stage of pregnancy.

Princeton, New Jersey
NCT07055607Enrolling by invitation
Real-world study of Wegovy for weight management

This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.

Barcelona
NCT07280221Enrolling by invitation
Wegovy real-world weight loss study in Korea

This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.

Daejeon
NCT06738979Not yet recruiting· Phase 3
Comparing semaglutide injection to Wegovy® for weight loss

This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.

Hefei, Anhui
NCT05807594Recruiting
Online program to help manage weight gain during pregnancy

This trial tests an at-home (online) coaching program to help pregnant people gain weight at a healthier rate. It may help you stay on track during pregnancy and understand what changes work best for you.

University Park, Pennsylvania
NCT07423481Not yet recruiting
Weight changes on Wegovy in severe obesity

This study is looking at weight changes and factors that affect weight loss in people with severe or complicated obesity who have already started taking Wegovy. Researchers hope to learn what helps predict success with this medication.

Nantes

Hear when a new Pregnancy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.